t911 p21-22q23 MLL-AF9 PCR Qualitative Test sale cost 1000 AED
T119 q23p13.3 TCF3-BX1E2A-PBX1 PCR Qualitative Test sale cost 1170 AED T119 q23p13.3 TCF3-BX1E2A-PBX1 PCR Qualitative Test Cost 1,300 د.إ Original price was: 1,300 د.إ.1,170 د.إCurrent price is: 1,170 د.إ.
AML ETO t821 Gene Rearrangement PCR Qualitative Test sale cost 1000 AED AML ETO t821 Gene Rearrangement PCR Qualitative Test Cost 1,200 د.إ Original price was: 1,200 د.إ.1,000 د.إCurrent price is: 1,000 د.إ.
Sale!

t911 p21-22q23 MLL-AF9 PCR Qualitative Test Cost

Original price was: 1,300 د.إ.Current price is: 1,000 د.إ.

-23%

The T(9;11)(p21-22;q23) MLL-AF9 PCR Qualitative Test is a highly specialized diagnostic procedure designed to detect the presence of the MLL-AF9 gene fusion, which results from a translocation between chromosomes 9 and 11. This genetic anomaly is primarily associated with certain types of leukemia, including acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). The test employs Polymerase Chain Reaction (PCR) technology, a sensitive and specific method, to identify the fusion gene’s unique DNA sequence, thereby aiding in the diagnosis, prognosis, and management of patients with leukemia.

Performed at DNA Labs UAE, a leading facility in genetic and molecular diagnostics, this test ensures high accuracy and reliability. The cost of the T(9;11)(p21-22;q23) MLL-AF9 PCR Qualitative Test is set at 1000 AED. Given the complexity of the test and the critical information it provides, the price reflects the sophisticated technology and expertise required to conduct such an analysis. By identifying the MLL-AF9 fusion gene, healthcare providers can tailor treatment strategies more effectively, potentially improving patient outcomes in those affected by leukemia associated with this genetic translocation.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

t911 p21-22q23 MLL-AF9 PCR QUALITATIVE Test

Test Cost: AED 1000.0

Overview

The t911 p21-22q23 MLL-AF9 PCR QUALITATIVE Test is a diagnostic test offered by DNA Labs UAE. It is designed to detect the presence of a specific chromosomal translocation in cells. This test is particularly useful in diagnosing certain types of leukemia, including acute myeloid leukemia (AML) with MLL rearrangements.

Test Components

  • Price: AED 1000.0
  • Sample Condition: 3mL (2mL min.) whole blood/bone marrow in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE.
  • Clinical History: Mandatory
  • Report Delivery: Sample collected on Monday/Thursday at 11am, report delivered on Wednesday/Saturday

Method

The t911 p21-22q23 MLL-AF9 PCR QUALITATIVE Test is performed using a technique called Real Time PCR. This method amplifies specific DNA sequences in the sample, allowing for the detection of the MLL-AF9 fusion gene.

Test Type

This test is primarily used for the diagnosis of leukemia, specifically cases involving MLL rearrangements.

Doctor

This test is typically ordered by an Oncologist.

Test Department

This test is conducted in the Molecular Diagnostics department of DNA Labs UAE.

Pre Test Information

Clinical history is mandatory for this test.

Test Details

The t(911) (p21-22q23) (MLL-AF9) PCR qualitative test is a laboratory test performed by trained professionals. It involves the detection of a specific chromosomal translocation in cells, specifically the fusion of the MLL gene on chromosome 11 with the AF9 gene on chromosome 9. The test utilizes the polymerase chain reaction (PCR) technique to amplify specific DNA sequences in the sample.

The PCR qualitative test is used to determine if the MLL-AF9 fusion gene is present in the patient’s cells, indicating the presence of the t(911) (p21-22q23) chromosomal translocation. The results of this test can be used to diagnose certain types of leukemia, monitor the response to treatment, and detect minimal residual disease (MRD) in patients with MLL-AF9-positive leukemia.

It is important to note that this test requires a sample of the patient’s blood or bone marrow. The results are typically reported as either positive or negative for the MLL-AF9 fusion gene.

Test Name t911 p21-22q23 MLL-AF9 PCR QUALITATIVE Test
Components
Price 1000.0 AED
Sample Condition 3mL(2mLmin.) wholeblood\/Bone marrowin1LavenderTop(EDTA) tube.Shiprefrigerated.DONOT FREEZE. Clinical history is mandatory.
Report Delivery Sample Mon / Thu11am;Report Wed / Sat
Method Real Time PCR
Test type Leukemia
Doctor Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Clinical history is mandatory.
Test Details

The t(911) (p21-22q23) (MLL-AF9) PCR qualitative test is a diagnostic test used to detect the presence of a specific chromosomal translocation in cells. This translocation involves the fusion of the MLL gene on chromosome 11 with the AF9 gene on chromosome 9.

The test is performed using a technique called polymerase chain reaction (PCR), which amplifies specific DNA sequences in the sample. The PCR qualitative test is used to determine if the MLL-AF9 fusion gene is present in the patient’s cells, indicating the presence of the t(911) (p21-22q23) chromosomal translocation.

The test results can be used to diagnose certain types of leukemia, particularly acute myeloid leukemia (AML) with MLL rearrangements. It can also be used to monitor the response to treatment and detect minimal residual disease (MRD) in patients with MLL-AF9-positive leukemia.

It is important to note that the t(911) (p21-22q23) (MLL-AF9) PCR qualitative test is a laboratory test performed by trained professionals. The test requires a sample of the patient’s blood or bone marrow, and the results are typically reported as positive or negative for the MLL-AF9 fusion gene.

SKU: TEST-5702 Category:

Related products